Normal
The companies sales are also being constantly challenged by out-of-patent generic pharmaceutical-makers in places like India. Couple this with what has already been posted and this is a bow-wow that no Daddy should buy. IMO.DYOR
The companies sales are also being constantly challenged by out-of-patent generic pharmaceutical-makers in places like India. Couple this with what has already been posted and this is a bow-wow that no Daddy should buy. IMO.
DYOR
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.
